Abstract:Malignant gliomas are the most common tumor in central nervous system with poor prognosis. Due to the limitation of histological classification in earlier diagnosis and individualized medicine, it is necessary to combine the molecular signatures and the pathological characteristics of gliomas. Lots of microRNAs presented abnormal expression in gliomas and modulated gliomas development. Exploration the miRNAs profile is helpful for the diagnosis, therapy and prognosis of gliomas. It has been demonstrated that miR-144 plays important roles in solid tumors. However, the detail mechanisms remained unrevealed. In this study, we have demonstrated the level of miR-144 decreased in glioma tissues from patients, especially in gliomas with higher grades. MiR-144 was also validated have lower expression in glioma cell lines compared with cortical neuron cell by using qRT-PCR. The in vitro functional experiment indicated miR-144 improved gliomas progression through repressing proliferation, sensitizing to chemotherapeutics and inhibiting metastasis. We further identified fibroblast growth factor 7 (FGF7) and Caveolin 2 (CAV2) were target genes of miR-144 by luciferase reporter assay and western blotting. The mechanisms study suggested forced FGF7 expression elevated Akt activation and decreased reactive oxygen species (ROS) generation. The MTT and cell cycle assay indicated miR-144 suppressed glioma cells proliferation through modulating FGF mediated Akt signaling pathway. Meanwhile, miR-144 promoted Temozolomide (TMZ) induced apoptosis in glioma cells via increasing ROS production by using FACS. On the other hand, CAV2, as another target of miR-144, accelerated glioma cells migration and invasion via promoting glioma cells EMT progress. Retrieved expression of FGF7 or CAV2 rescued the proliferation and migration function mediated by miR-144. Furthermore, the in vivo experiments in PDX models displayed the anti-tumor function of miR-144, which could be retrieved by overexpression of FGF7 and CAV2. Taken together, these findings indicated miR-144 acted as a potential target against gliomas progression and uncovered a novel regulatory mechanism, which may provide a new therapeutic strategy and prognostic indicator for gliomas.

Research Progress of MicroRNA in Glioma

Advance of MicroRNAs Research in Gliomas

Mir-3184-3p Enriched in Cerebrospinal Fluid Exosomes Contributes to Progression of Glioma and Promotes M2-like Macrophage Polarization.

A Predicted Mir-27A-mediated Network Identifies a Signature of Glioma.

Research Progress of MicoRNA in Molecular Targeting Treatment of Hepatocellular Carcinoma

MicroRNA Enters Glioblastoma World

Research Progress of microRNA-761

Role of MicroRNAs in Malignant Glioma

The role of microRNA in the pathogenesis of glial brain tumors

Research Progress on Lung Cancer Related MicroRNAs

MicroRNAs, Key Regulators in Glioma Progression as Potential Therapeutic Targets for Chinese Medicine

MicroRNAs as prognostic markers and therapeutic targets in gliomas

Investigation gene and microRNA expression in glioblastoma

Progresses on the study of microRNA and cancer

The Progression of Microrna and Tumor's Research

MicroRNA-144 Represses Gliomas Progression and Elevates Susceptibility to Temozolomide by Targeting CAV2 and FGF7

Molecular mechanism of Notch signaling with special emphasis on microRNAs: Implications for glioma

Roles of microRNA-99 family in human glioma.

miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.

Mir-508-5p Inhibits the Progression of Glioma by Targeting Glycoprotein Non-Metastatic Melanoma B

The biological and diagnostic roles of MicroRNAs in meningiomas